Results 271 to 280 of about 788,607 (367)

Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study. [PDF]

J Clin Med
Escobar C, Palacios B, Villarreal M, Gutiérrez M, Capel M, Hernández I, García M, Lledó L, Arenillas JF.   +8 more
europepmc   +1 more source

Introduction to direct oral anticoagulants and rationale for specific reversal agents. [PDF]

, 2016
Pollack, Charles V.
core   +2 more sources

Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa-inhibitor edoxaban

, 2010
Y Morishima, Toshiro Shibano
openalex   +2 more sources

Heparin Calibrated Anti-Xa Assays for the Measurement of Low Levels of Direct Factor Xa Inhibitors [PDF]

, 2017
Dogne, Jean-Michel, Douxfils, Jonathan, Mullier, François, Raphaël, Mélanie, Sabor, Lina   +4 more
core  

Thrombin Inhibitor or Factor Xa Inhibitor?

, 2011
Hirotsugu Atarashi
openalex   +2 more sources

Lysis of thrombus located in the left atrial appendage. Is it the right time for a Xa factor inhibitor?

, 2013
Jakub Baran, Beata Zaborska, Małgorzata Sikora-Frąc, Sebastian Stec, Piotr Kułakowski   +4 more
openalex   +2 more sources

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. [PDF]

Clin Pharmacokinet
Rohr BS, Krohmer E, Foerster KI, Burhenne J, Schulz M, Blank A, Mikus G, Haefeli WE.   +7 more
europepmc   +1 more source

Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation

Cochrane Database of Systematic Reviews, 2013
K. B. Slot, E. Berge
semanticscholar   +1 more source

Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study. [PDF]

Eur Stroke J
Diener HC, Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Maurer GD, Soda H, Pohlmann C, Hilker-Roggendorf R, Popovic N, Kraft P, Mackert BM, Eschenfelder CC, Weimar C.   +14 more
europepmc   +1 more source

Betrixaban: An Oral Factor Xa Inhibitor [PDF]

Clinical Research and Trials, 2017
openaire   +1 more source